Health Affairs July 6, 2017
Travis Broome and Farzad Mostashari

Similar to private health insurance, there is little competition in Medicare Advantage (MA). The US District Court’s recent decision against the Aetna-Humana merger is a strong signal that the current Medicare Advantage market does not favor new entry. According to the Justice Department’s expert testimony in the case, only 5.5 percent of the 284 complaint counties experienced new entry from 2012 to 2016 from plans that were not either Humana or Aetna.

Yet Medicare Advantage does not have to be constrained in this way. Innovative provider groups have shown it is possible to launch an MA plan even when it may not be possible to launch a commercial insurance product. As provider groups gain experience through accountable care models, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Health System / Hospital, Medicare Advantage, Patient / Consumer, Payer, Physician, Primary care, Provider
Home-Based Care Outlook: 55% of Leaders Name Staffing as Top Challenge, Tech Investment on Rise
How doctors lost their freedom and what it means for health care today
The biggest expenses crushing physician practices
Three ways the Trump administration could reinvest in rural America's future, starting with health care
Using AI to reimagine telehealth with a fair, effective billing model

Share This Article